Heather Greene, MSN, FNP, AOCNP

About Me

Heather joined West Cancer Center in 2011, having been an oncology nurse practitioner since 2002. She currently works in the outpatient setting, managing a variety of medical oncology patients including those with genitourinary (GU) and gastrointestinal (GI) cancers, in which her collaborating physician has a special interest. She is also a sub-investigator on several GU and GI protocols at West. In addition to her clinical practice, she is one of three Lead Advanced Practice Providers (APPs) at West Cancer Center, helping mentor and guide over 40 APPs in their role and practice.

Heather earned her BSN in 2000 and her MSN in 2002, both from the University of Tennessee. She has been a contributing author on several occasions for the Journal of the Advanced Practitioner in Oncology (JADPRO) and the Oncology Nursing Society.  She has spoken at multiple local, regional and national Advanced Practice meetings, including West Oncology Annual Conference, Oncology Nursing Society’s Annual Congress and JADPROLive!. She co-chaired APPOS Nashville for three years and this year she again  co-chaired the Annual West Oncology Conference: Updates for Advanced Practitioners and Nurses.

Education

• Master of Science in Nursing, Family Nurse Practitioner
  • University of Tennessee, College of Nursing
• Bachelor of Science in Nursing
  • University of Tennessee, College of Nursing

Licenses/Certifications

• • 2011-present: Licensed Advanced Practice Nurse, State of Mississippi
  • 2006-present: Advanced Oncology Certified Nurse Practitioner (AOCNP)
  • 2004-2006: Advanced Cardiac Life Support (ACLS) Provider
  • 2003-present: Certified Nurse Practitioner, American Nurses Credentialing Center (ANCC)
  • 2003-present: Certificate of Fitness to Prescribe & DEA
  • 2002-present: Licensed Advanced Practice Nurse, State of Tennessee
  • 2001: Chemotherapy Administration Certification Class
  • 2000-present: Registered Nurse, State of Tennessee
  • 1998-present: Basic Life Support (BLS) Provider

Lectures / Public Speaking

• • February 2024: GI Panel Participant West Cancer Center Annual West Oncology Conference—Memphis, TN
  • February 2023: GU Panel Participant, GI Panel Participant, Molecular Panel Participant, West Cancer Center Annual West Oncology Conference—Memphis, TN
  • October 2021-present: Co-Chair Annual West Oncology Conference: Updates for Advanced Practitioners and Nurses—Virtual Meeting, Memphis, TN
  • March 2021: Toxicity Management: Advances in Cancer Immunotherapy Society for Immunotherapy of Cancer, Virtual Meeting
  • 2020-2023: Co-Chair Annual Advanced Practive Provider Oncology Summit—Nashville, TN
  • February 2020: GU Panel West Oncology Conference—Memphis, TN
  • October 2019: Grand Rounds in Breast Cancer: Current Trends in HR+ HER2- Breast Cancer Management; JADPRO Live!, Seattle, Washington
  • November 2018: OncLive State of the Science Lecture: RCC, Managing Side Effects of RCC Therapy
  • February 2018: OncLive State of the Science Lecture: Advanced NSCLC, Treating Side Effects of Immunotherapy; Memphis, TN
  • August 2016-present: Nurse Speaker, Pfizer; multiple presentations to nurses and patients ER+/Her2- metastatic breast cancer
  • November 2016: Grand Rounds in Breast Cancer: Collaborative Management of patients with Advanced ER+ Breast Cancer; JADPRO Live!, Washington D.C.
  • November 2014: Grand Rounds in Breast Cancer: Hormone Receptor Positive Advanced Breast Cancer; JADPRO Live!, Orlando, FL
  • January 2014: Metastatic Breast Cancer: Overcoming Resistance to First Line Therapy; JADPRO Live!, St. Petersburg, FL
  • December 2013: Lung Cancer Screening Guidelines 2014; Champions of Cancer Symposium, Memphis, TN
  • April 2011: Cancer Screening Guidelines; ONS Congress, Boston, MA
  • February 2009: Breast Cancer Survivors: Surveillance After Adjuvant Therapy; Tri-Cities Breast Cancer Support Group, Bristol, TN
  • April 2007: Skin Cancer Awareness: Screening and Prevention; Cherokee United Methodist Church, Johnson City, TN
  • October 2006: Cancer Awareness: Screening and Prevention; Cherokee United Methodist Church, Johnson City, TN
  • October 2005: Community Breast Cancer Awareness Workshop; Bristol Regional Medical Center, Bristol, TN

Research

• • 2011 – Present: Sub-Investigator, West Cancer Center
  • 2005 – 2011: Sub-Investigator, Blue Ridge Medical Specialists, P.C.

Publications

• • Greene, H. (2024). “Rx Road Map: Erdafitinib (Balversa).” Oncology Nursing News. https://www.oncnursingnews.com/view/rx-road-map-erdafitinib-balversa-
  • Greene, H., Krise, K. JADPRO Expert Conversations on Metastatic Colorectal Cancer, 3-part series. May-July 2024 https://conversations.advancedpractitioner.com/
  • ESMO 2023 World Congress on Gastrointestinal Cancer Serial ctDNA monitoring during immunotherapy (IO) in patients (pts) with MSI-H/dMMR advanced colorectal cancer (CRC)
  • ESMO 2022 World Congress on Gastrointestinal Cancer Performance Characteristics of a Tumor-Informed Circulating Tumor DNA (ctDNA) Minimal Residual Disease (MRD) Assay in Stage 1-3 Colorectal Cancer (CRC) in Clinical Practice
  • Greene, H. (2016). Cancer Screening. In Gobel, B.H., Triest-Robertson, S. & Vogel, W. (Eds.), Advanced Oncology Certification Review and Resource Manual, 2^nd Edition. Pittsburgh, PA: Oncology Nursing Society.
  • Greene, H. (2010). Streamlining needs for everyday practice: Three websites that make your life easier. Journal for the Advanced Practitioner in Oncology 1(4), 290-291.
  • Greene, H. (2009). Cancer Screening. In Gobel, B.H., Triest-Robertson, S. & Vogel, W. (Eds.), Advanced Oncology Certification Review and Resource Manual. Pittsburgh, PA: Oncology Nursing Society.
  • Greene, H. (2007). So, What About Guidelines for Practice? In Vogel, W. (Ed.), So, You Want to be an Oncology Nurse Practitioner? Pittsburgh, PA: Oncology Nursing Society.